Products sold online claiming to be tejocote root are in fact yellow oleander, which is toxic. FDA warns consumers to stop using the products, which are sold under a variety of brand names.
Whitebarrel Winery announced its plans to close earlier this month, a move that will begin with the shuttering of its tasting room and dining operations on Sunday.
Press release content from Business Wire. The AP news staff was not involved in its creation.
New Study Presents Evidence of Effectiveness and Safety Of Oleandrin and Phoenix Biotechnology’s PBI-06150 Against SARS-CoV-2
March 17, 2021 GMT
An article published last week in the
Journal of Biomedicine & Pharmacotherapy ( www.elsevier.com/locate/biopha; Vol 138 (2021) 111457) presents
in vitro evidence for significant inhibition of SARS-CoV-2 by oleandrin and a defined extract of
N. oleander (developed by Phoenix Biotechnology, Inc. and designated as PBI-06150), as well as
in vivo evidence of the safety and efficacy of PBI-06150.
ADVERTISEMENT
The
Journal of Biomedicine & Pharmacotherapy is an open access, peer-reviewed medical journal covering medical applications of pharmacology. It was established in 1956 and is published 10 times a year.
New Study Presents Evidence of Effectiveness and Safety Of Oleandrin and Phoenix Biotechnology s PBI-06150 Against SARS-CoV-2 marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
December 17, 2020
The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
Today, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC), made up of independent scientific and public health experts from around the country, met to discuss a request for emergency use authorization (EUA) for a vaccine for COVID-19 prevention, submitted by ModernaTX, Inc. This meeting is an important step in the review process, providing an opportunity for outside experts to provide valuable advice and input for the agency to consider as part of its review. Importantly, the final decision about whether to authorize the vaccine for emergency use will be made by FDA’s career officials.